120
Participants
Start Date
September 20, 2016
Primary Completion Date
September 27, 2017
Study Completion Date
September 27, 2017
XC8 Oral Tablet
1 tablet of XC8 in a dose according to the treatment group + 2 tablets of placebo (in total 3 tablets) once daily in the morning during 12 weeks of treatment period.
Placebo Oral Tablet
Placebo (in total 3 tablets) once daily in the morning during 12 weeks of treatment period.
"Saint Petersburg State Monetary Healthcare Institution Nicolaevskiy Hospital", Saint Petersburg
"Pulmonology Research Institute FMBA of Russia", Moscow
Central Research Institute for Tuberculosis at Russian Medical Sciences, Moscow
"Moscow State Medical-Dentist University n.a. A.I. Evdokimov on basis of SMHI City Hospital № 62, branch 5", Moscow
Russian Medical Academy of postgraduate education of Ministry of Healthcare on basis of city's Clinical Hospital № 52, Moscow
"State autonomous healthcare institution of Yaroslavl Region Сlinical hospital for emergency medical care n. a. N.V. Solovyov", Yaroslavl
"State Budgetary Institution of Healthcare Leningrad region Clinical Hospital", Saint Petersburg
"Medical Researches Institute LLC", Saint Petersburg
"Federal State Budgetary Educational Institution of the Higher Education Smolensk State Medical", Smolensk
"Allergy and Immunology Center LLC", Krasnodar
Ryazan State Medical University, Ryazan
"State Healthcare Institution Regional Clinical Hospital", Saratov
EURRUS Biotech GmbH
INDUSTRY
PHARMENTERPRISES LLC
INDUSTRY